Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-016978
Filing Date
2019-03-29
Accepted
2019-03-29 16:06:48
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv516837_s3.htm S-3 265749
2 EXHIBIT 4.3 tv516837_ex4-3.htm EX-4.3 359708
3 EXHIBIT 4.4 tv516837_ex4-4.htm EX-4.4 340217
4 EXHIBIT 5.1 tv516837_ex5-1.htm EX-5.1 19774
5 EXHIBIT 23.1 tv516837_ex23-1.htm EX-23.1 3923
6 GRAPHIC tv516837_img01.jpg GRAPHIC 12363
7 GRAPHIC tv516837_img02.jpg GRAPHIC 26704
8 GRAPHIC tv516837_img03.jpg GRAPHIC 4258
  Complete submission text file 0001144204-19-016978.txt   1050674
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230604 | Film No.: 19716453
SIC: 2836 Biological Products, (No Diagnostic Substances)